Exosome Therapy
Exosome Therapy
Regenerative-Medicine Product Information
Exosome Therapy
Exosomes are microscopic particles released by cells and studied for their role in cell-to-cell communication. Products marketed as containing exosomes are sometimes promoted for aesthetic or regenerative purposes. However, in the United States, there are currently no FDA-approved exosome products, and safety, quality, purity, potency, and effectiveness cannot be assumed from marketing claims alone.
Current U.S. Status
No FDA-Approved Exosome Products
Appropriate Context
FDA-Overseen Clinical Research Only
What Are Exosomes?
Exosomes are extracellular vesicles that can carry proteins, lipids, and genetic material between cells. Their biological functions are an active area of laboratory and clinical research. A product labeled “exosomes” may differ substantially in cellular source, manufacturing process, concentration, purity, storage, sterility, and biological activity.
What Patients Should Understand
Research Is Ongoing
Scientific interest does not establish that a marketed product is safe, effective, pure, potent, or appropriate for cosmetic treatment.
Products Are Not Interchangeable
Source material, isolation methods, formulation, dose, and quality controls can vary widely between products.
Topical and Injectable Use Differ
A product applied to intact skin is not equivalent to a product injected or introduced through microneedling, laser, or another procedure.
Claims Require Evidence
Terms such as repair, regeneration, rejuvenation, stem-cell derived, or medical grade do not prove clinical benefit or regulatory approval.
Questions to Ask Before Considering a Product
Patients should request clear documentation rather than relying on promotional language, social-media claims, or before-and-after images.
Exact Product
Name, Source & ManufacturerAsk for the full product name, manufacturer, tissue or cellular source, lot information, and instructions for use.
Regulatory Status
FDA Review or INDAsk whether FDA has approved the product or whether treatment is being conducted under an FDA-authorized Investigational New Drug application.
Clinical Oversight
IRB & Informed ConsentFor regulated research, ask about the clinical-trial sponsor, investigator, Institutional Review Board, consent process, and adverse-event monitoring.
What Legitimate Clinical Research Involves
Eligibility Review
A research team evaluates whether a participant meets the study’s inclusion and exclusion criteria.
Informed Consent
Participants receive information about the experimental product, known and unknown risks, alternatives, privacy, and study oversight.
Structured Monitoring
The protocol defines dosing, administration, follow-up, adverse-event reporting, and conditions for stopping treatment.
Important U.S. Regulatory Notice
Exosome products intended to treat diseases or conditions are generally regulated as drugs and biological products and are subject to premarket review and approval requirements.
DermaPhi Does Not Present Exosome Products as FDA Approved
There are currently no FDA-approved exosome products. Products offered outside FDA oversight may be unapproved drugs or unlicensed biological products. FDA has reported serious adverse events associated with unapproved products marketed as containing exosomes. This informational page should not be interpreted as an offer to administer an exosome product outside a properly authorized clinical investigation.
Frequently Asked Questions
Are exosomes the same as stem cells?
No. Exosomes are extracellular vesicles released by cells; they are not living stem cells. Products may nevertheless be marketed using stem-cell-related terminology depending on their claimed source.
Are exosome products FDA approved?
No. FDA states that there are currently no FDA-approved exosome products.
Can exosomes be applied after microneedling or laser treatment?
Introducing a product through disrupted skin can create different risks than applying it to intact skin. Do not assume that an exosome product is authorized, sterile, or proven safe for post-procedure use.
Does “medical grade” mean FDA approved?
No. “Medical grade” is not a substitute for FDA approval, licensure, clearance, or authorization. Ask for the exact regulatory documentation for the specific product and intended use.
Are topical exosome products proven to rejuvenate skin?
Marketing claims should not be treated as proof. Evidence, formulation quality, skin penetration, stability, and safety may vary by product, and clinical benefit cannot be assumed.
What are the possible risks?
Risks may include contamination, infection, immune or inflammatory reactions, allergic reactions, tissue injury, unexpected biological effects, delayed appropriate care, and complications related to the method of administration.
How can I verify a clinical trial?
Ask the investigator for the FDA-issued IND number, the FDA communication acknowledging the IND, the study consent form, the IRB information, and the clinical investigator’s brochure when applicable.
Should I report a bad reaction?
Yes. Seek appropriate medical care and report suspected adverse events involving an exosome or other unapproved regenerative product to FDA’s MedWatch program.
This page provides general educational information and does not advertise, recommend, diagnose, prescribe, or offer an unapproved exosome product. There are currently no FDA-approved exosome products. Unapproved products may not have been reviewed for safety, effectiveness, quality, purity, or potency and may cause serious harm. Anyone considering participation in exosome research should verify FDA and Institutional Review Board oversight, review the informed-consent documents, and consult an independent qualified healthcare professional.
